Investigators proposed an optimized process using cord blood to generate minimally differentiated T-cell products in terms of phenotype, function, gene expression, and metabolism, using peripheral blood-derived T cells cultured with IL-2 as a standard.
[Cancer Gene Therapy]
6445218
{6445218:AAAAAAAA}
apa
50
1
167762
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
